Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Prognosis Influence of Additional Chromosome Abnormalities in Newly Diagnosed Acute Promyelocytic Leukemia with t(15;17)(q22;q21)

Lin Liu, Jinghan Wang, Huan Xu, Shuqi Zhao, Liangshun You, Jiansong Huang, Jie Jin

Blood (2023) 142 (Supplement 1): 5832.

https://doi.org/10.1182/blood-2023-179831

Published: 2023

Journal Articles

Safety and Efficacy of GPRC5D CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients

Shiqi Li, Zhongtao Yuan, Lin Liu, Yu Li, Le Luo, Yingnian Chen, Lihua Zhang, Guangchao Li, Min Luo, Kaikai Zeng, Donghui Ma, Sanbin Wang, Sr.

Blood (2023) 142 (Supplement 1): 3472.

https://doi.org/10.1182/blood-2023-179147

Published: 2023

Journal Articles

Venetoclax Plus Azacitidine, Low Dose Cytarabine, Aclarubicin and G-CSF (VA-CAG Regimen) for Newly Diagnosed Young Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase 2 Clinical Trial

Xiaoping Li, Xiaoyan Li, Yanling Jin, Zucong Chen, Yonglin Shen, Zhongtao Yuan, Lin Liu, Yu Li, Le Luo, Shiqian Hou, Chaoyang Zhou, Chie Qiu, Kui Zhang, Chunfu Li, Yang Liang, Sanbin Wang, Sr.

Blood (2023) 142 (Supplement 1): 834.

https://doi.org/10.1182/blood-2023-174469

Published: 2023

Journal Articles

The Different Impacts of an MRD-Guided Protocol on Relapse of Childhood Acute Lymphoblastic Leukemia: The Report of Taiwan Pediatric Oncology Group (TPOG)-ALL-2013

Blood (2023) 142 (Supplement 1): 1462.

https://doi.org/10.1182/blood-2023-186805

Published: 2023

Journal Articles

Iron Deficiency in Young Children Beyond Anemia: Clinical Features, Maternal Factors, and the Predictor for Neuropsychomotor Development Delay

Mei-Mei Cheng, Ching-Heng Hsiao, Yen-Lin Liu, Hsi Chang, Ya-Lin Lee, Min-Lan Tsai, Wan-Ling Ho, Sung-Hui Tseng, Tefu Weng, Chia-Yau Chang

Blood (2023) 142 (Supplement 1): 5233.

https://doi.org/10.1182/blood-2023-173129

Published: 2023

Journal Articles

The Correlation of Muscle Mass and Walking Distance with Joint Health and Functional Status in Hemophilic Arthropathy Among People with Hemophilia a (PwHA)

Chia-Yau Chang, Jia-Pei Hong, Chian-Her Lee, Shu-Huey Chen, Yen-Lin Liu, Yeu-Chin Chen, Jia-Ruey Tsai, Chen-Hua Tsai, Wan-Ling Ho, Chih-Hong Lee, Jiunn-Horng Kang

Blood (2023) 142 (Supplement 1): 3987.

https://doi.org/10.1182/blood-2023-173113

Published: 2023

Journal Articles

Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone in Early Relapsed/Refractory Multiple Myeloma

Anupama Kumar, Aaron S Rosenberg, Michelle Padilla, Nina Shah, Lindsey Sirianni, Lin Liu, Yuwei Cheng, Emily Pittman, Dimitrios Tzachanis, Sarah Larson, Carolyn Mulroney, Edward D. Ball, Caitlin Costello

Blood (2022) 140 (Supplement 1): 4436–4437.

https://doi.org/10.1182/blood-2022-169838

Published: 2022

Journal Articles

Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data

Jia Chen, Yiyang Ding, Xi Zhang, Erlie Jiang, Lin Liu, He Huang, Jiong Hu, Jishi Wang, Yanming Zhang, Myriam Labopin, Irma Khvedelidze, Emmanuelle Polge, Arnon Nagler, Mohamad Mohty, Depei Wu, Norbert Claude Gorin, Sr.

Blood (2022) 140 (Supplement 1): 12952–12953.

https://doi.org/10.1182/blood-2022-165709

Published: 2022

Journal Articles

A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL

Lijun Zhao, Shuhong Li, Xiaoyi Wei, Xuexiu Qi, Dong Liu, Lei Liu, Feiqiu Wen, Ji-shuai Zhang, Feng Wang, Ze-lin Liu, Yu J. Cao

Blood (2022) 140 (16): 1790–1802.

https://doi.org/10.1182/blood.2022016243

Published: 2022

Includes: Supplemental data

Journal Articles

Clinical Predictors and Prediction Models for Frequency of Total and Joint Hemorrhage in Severe-Type Patients with Hemophilia a (PwHA) with/without Intermediate-Dose Prophylaxis Therapy with rFVIII

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Jung-Tzu Ku, Shu-Hsia Hu, Chen-Hua Tsai, Pei-Yi Lai, Yen-Lin Liu, Jia-Ruey Tsai, Chao-Neng Cheng, Yeu-Chin Chen

Blood (2021) 138 (Supplement 1): 1047.

https://doi.org/10.1182/blood-2021-147069

Published: 2021

Journal Articles

Baseline VWF:Ag Level and Body Mass Index Are Inverse Influencing Factors of Annualized Total Bleeding Rate and Annualized Joint Bleeding Rate Respectively in Severe-Type Adult Patients with Hemophilia a (PwHA) with Episodic Treatment with rFVIII

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Jung-Tzu Ku, Shu-Hsia Hu, Jia-Ruey Tsai, Chen-Hua Tsai, Pei-Yi Lai, Yen-Lin Liu, Chao-Neng Cheng, Yeu-Chin Chen

Blood (2021) 138 (Supplement 1): 3199.

https://doi.org/10.1182/blood-2021-150822

Published: 2021

Journal Articles

Real-World Bleeding Outcomes, Weekly Factor Consumption Doses, Annualized Factor Costs in Severe-Type Patients with Hemophilia a (PwHA) before and after Switching to Extended Half-Life rFVIII-Fc Prophylaxis

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Pei-Yi Lai, Jung-Tzu Ku, Shu-Hsia Hu, Chen-Hua Tsai, Chao-Neng Cheng, Yen-Lin Liu, Jia-Ruey Tsai, Yeu-Chin Chen

Blood (2021) 138 (Supplement 1): 3198.

https://doi.org/10.1182/blood-2021-152066

Published: 2021

Journal Articles

Novel CD19-Specific γ/δ TCR-T Cells in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Chenggong Li, Qi Chang, Jing Wang, Mengyi Du, Lin Liu, Haiming Kou, Cong Lu, Lu Tang, Jianghua Wu, Wenjing Luo, Yinqiang Zhang, Sha Ke, Jun Deng, Cheng Liu, Yu Hu, Heng Mei

Blood (2021) 138 (Supplement 1): 826.

https://doi.org/10.1182/blood-2021-152661

Published: 2021

Journal Articles

The Real-World Experience of rFVIII-Fc Used in Hemophilia a Patients in Taiwan: Prophylaxis Rates, Pharmacokinetics and Clinical Correlates, and the Effects on Joint Health

Chia-Yau Chang, MD, Yeu-Chin Chen, MD, Chen-Hua Tsai, MD, Jia-Ruey Tsai, MD, Yen-Lin Liu, MD, Shu-Hsia Hu

Blood (2019) 134 (Supplement_1): 2406.

https://doi.org/10.1182/blood-2019-132137

Published: 2019

Journal Articles

A Bispecific CAR-T Cell Therapy Targeting Bcma and CD38 for Relapsed/Refractory Multiple Myeloma: Updated Results from a Phase 1 Dose-Climbing Trial

Chenggong Li, Heng Mei, Yu Hu, MD PhD, Tao Guo, MD PhD, Lin Liu, MD PhD, Huiwen Jiang, Lu Tang, Yaohui Wu, MD PhD, Lisha Ai, MD PhD, Jun Deng, MD PhD, Dan Jin

Blood (2019) 134 (Supplement_1): 930.

https://doi.org/10.1182/blood-2019-130340

Published: 2019

Journal Articles

A Phase II Study of Pegylated Asparaginase, Cyclophosphamide, Rituximab, and Dasatinib Added to the UCSF 8707 (Linker 4-drug) Regimen with Liposomal Cytarabine CNS Prophylaxis for Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): University of California Hematologic Malignancies Consortium Study (UCHMC) 1401

Matthew J. Wieduwilt, MD PhD, Brian A. Jonas, MD, Gary J. Schiller, MD, Lin Liu, PhD, Carolyn Mulroney, MD, Gabriel N. Mannis, MD, Dimitrios Tzachanis, MD PhD, Januario E. Castro, MD, Edward D Ball, MD, Peter T. Curtin, MD, Charalambos Andreadis, MD, Aaron C. Logan, MD PhD, Jesika Reiner, MPH, Lloyd E. Damon, MD

Blood (2018) 132 (Supplement 1): 4018.

https://doi.org/10.1182/blood-2018-99-117469

Published: 2018

Journal Articles

A Refined Regimen for Maximally Eliminating Early Life-Threatening Complications for Patients with High-Risk Acute Promyelocytic Leukemia

Sanbin Wang, Lihui Peng, Lin Liu, Le Luo, Stephen Liang, MD

Blood (2018) 132 (Supplement 1): 3994.

https://doi.org/10.1182/blood-2018-99-118620

Published: 2018

Journal Articles

Outcome of Ruxolitinib and Sirolimus in Preventing aGVHD Post to HLA Matched Hemotopietic Stem Cell Transplantation

Sanbin Wang, Xiaoli Huang, Lin Liu, Yang Liang

Blood (2018) 132 (Supplement 1): 5727.

https://doi.org/10.1182/blood-2018-99-119109

Published: 2018

Journal Articles

Oral Arsenic Plus Retinoic Acid Versus Intravenous Arsenic Plus Retinoic Acid for Non-High Risk Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trials

Honghu Zhu, Depei Wu, MD, Xi Zhang, MD PhD, Lin LIU, Jun Ma, Zonghong Shao, MD, Hanyun Ren, MDPhD, Jianda Hu, Prof MDPhD, Kailin Xu, MD, PhD, Jing-Wen Wang, Yongping Song, Mei-Yun Fang, Xiao-Jun Huang, MD

Blood (2017) 130 (Supplement 1): 641.

https://doi.org/10.1182/blood.V130.Suppl_1.641.641

Published: 2017

Journal Articles

Tet2 Loss Dysregulates the Behavior of Mesenchymal Stem Cells and Increases Their Ability to Promote Tet2 -/- -Driven Myeloid Malignancy Progression

Zhigang Zhao, MD PhD, Rong Li, Lin Liu, Jinhuan Wang, Zizhen Chen, Wen Xing, MD, Weiping Yuan, PhDMD, Feng-Chun Yang, MD PhD, Yuan Zhou, PhD, Mingjiang Xu, MD PhD

Blood (2016) 128 (22): 1510.

https://doi.org/10.1182/blood.V128.22.1510.1510

Published: 2016

NARROW

Prognosis Influence of Additional Chromosome Abnormalities in Newly Diagnosed Acute Promyelocytic Leukemia with t(15;17)(q22;q21)

Safety and Efficacy of GPRC5D CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients

Venetoclax Plus Azacitidine, Low Dose Cytarabine, Aclarubicin and G-CSF (VA-CAG Regimen) for Newly Diagnosed Young Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase 2 Clinical Trial

The Different Impacts of an MRD-Guided Protocol on Relapse of Childhood Acute Lymphoblastic Leukemia: The Report of Taiwan Pediatric Oncology Group (TPOG)-ALL-2013

Iron Deficiency in Young Children Beyond Anemia: Clinical Features, Maternal Factors, and the Predictor for Neuropsychomotor Development Delay

The Correlation of Muscle Mass and Walking Distance with Joint Health and Functional Status in Hemophilic Arthropathy Among People with Hemophilia a (PwHA)

Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone in Early Relapsed/Refractory Multiple Myeloma

Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data

A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL

Clinical Predictors and Prediction Models for Frequency of Total and Joint Hemorrhage in Severe-Type Patients with Hemophilia a (PwHA) with/without Intermediate-Dose Prophylaxis Therapy with rFVIII

Baseline VWF:Ag Level and Body Mass Index Are Inverse Influencing Factors of Annualized Total Bleeding Rate and Annualized Joint Bleeding Rate Respectively in Severe-Type Adult Patients with Hemophilia a (PwHA) with Episodic Treatment with rFVIII

Real-World Bleeding Outcomes, Weekly Factor Consumption Doses, Annualized Factor Costs in Severe-Type Patients with Hemophilia a (PwHA) before and after Switching to Extended Half-Life rFVIII-Fc Prophylaxis

Novel CD19-Specific γ/δ TCR-T Cells in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

The Real-World Experience of rFVIII-Fc Used in Hemophilia a Patients in Taiwan: Prophylaxis Rates, Pharmacokinetics and Clinical Correlates, and the Effects on Joint Health

A Bispecific CAR-T Cell Therapy Targeting Bcma and CD38 for Relapsed/Refractory Multiple Myeloma: Updated Results from a Phase 1 Dose-Climbing Trial

A Refined Regimen for Maximally Eliminating Early Life-Threatening Complications for Patients with High-Risk Acute Promyelocytic Leukemia

Outcome of Ruxolitinib and Sirolimus in Preventing aGVHD Post to HLA Matched Hemotopietic Stem Cell Transplantation

Oral Arsenic Plus Retinoic Acid Versus Intravenous Arsenic Plus Retinoic Acid for Non-High Risk Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trials

Tet2 Loss Dysregulates the Behavior of Mesenchymal Stem Cells and Increases Their Ability to Promote Tet2 -/- -Driven Myeloid Malignancy Progression

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only